Citations (200)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Michael Safani, Steve Appleby, Ryan Chiu, Emmanuel J Favaloro, Emanuel T. Ferro, Jimmy Johannes & Milan Sheth. (2023) Application of anti-Xa assay in monitoring unfractionated heparin therapy in contemporary antithrombotic management. Expert Review of Hematology 16:1, pages 1-8.
Read now
Read now
Elvira Grandone, Michela Villani & Giovanni L Tiscia. (2015) Aspirin and heparin in pregnancy. Expert Opinion on Pharmacotherapy 16:12, pages 1793-1803.
Read now
Read now
Unjeria C. Jackson, Harold E. Fox, John Owen & Kenneth D. Friedman. (1992) The Administration of Antithrombin III in the Management of Severe Preeclampsia. Journal of Maternal-Fetal Medicine 1:6, pages 308-312.
Read now
Read now
L.T. Clement. (1983) Purification and Characterization of Guinea PIG Anti Thrombin III. Preparative Biochemistry 13:1, pages 1-20.
Read now
Read now
F. Jooyandeh, J.S. Moore & J.V. Davies. (1979) Interaction of Basic Amino Acids, Polypeptides and Proteins with Heparin. International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine 35:4, pages 487-491.
Read now
Read now
U. Abildgaard, M. Lie & O. R. ödegård. (1976) A Simple Amidolytic Method for the Determination of Functionally Active Antithrombin III. Scandinavian Journal of Clinical and Laboratory Investigation 36:1, pages 109-112.
Read now
Read now
U. Abildgaard. (1969) Binding of Thrombin to Antithrombin III. Scandinavian Journal of Clinical and Laboratory Investigation 24:1, pages 23-27.
Read now
Read now
P. O. Ganrot. (1969) Electrophoretic Separation of Two Thrombin Inhibitors in Plasma and Serum. Scandinavian Journal of Clinical and Laboratory Investigation 24:1, pages 11-14.
Read now
Read now
Articles from other publishers (192)
Armando Tripodi. (2022) Hemostasis from Bench to Bedside: The History of Three Successful Stories of Translational Medicine. Seminars in Thrombosis and Hemostasis 49:03, pages 234-241.
Crossref
Crossref
Pavel Cejnar, Tatiana Anatolievna Smirnova, Stepanka Kuckova, Ales Prochazka, Ivan Zak, Karel Harant & Sergey Zakharov. (2022) Acute and chronic blood serum proteome changes in patients with methanol poisoning. Scientific Reports 12:1.
Crossref
Crossref
Marco Heestermans, Géraldine Poenou, Hind Hamzeh-Cognasse, Fabrice Cognasse & Laurent Bertoletti. (2022) Anticoagulants: A Short History, Their Mechanism of Action, Pharmacology, and Indications. Cells 11:20, pages 3214.
Crossref
Crossref
Kemal Mese, Oskar Bunz, Wolfram Volkwein, Sahithya P. B. Vemulapalli, Wenli Zhang, Sebastian Schellhorn, Kristin Heenemann, Antje Rueckner, Andreas Sing, Thomas W. Vahlenkamp, Anna-Lena Severing, Jian Gao, Malik Aydin, Dominik Jung, Hagen S. Bachmann, Kurt S. Zänker, Ulrich Busch, Armin Baiker, Christian Griesinger & Anja Ehrhardt. (2021) Enhanced Antiviral Function of Magnesium Chloride-Modified Heparin on a Broad Spectrum of Viruses. International Journal of Molecular Sciences 22:18, pages 10075.
Crossref
Crossref
Manila Gaddh & Rachel P. Rosovsky. (2021) Venous Thromboembolism: Genetics and Thrombophilias. Seminars in Respiratory and Critical Care Medicine 42:02, pages 271-283.
Crossref
Crossref
Sultan N. Baytas & Robert J. Linhardt. (2020) Advances in the preparation and synthesis of heparin and related products. Drug Discovery Today 25:12, pages 2095-2109.
Crossref
Crossref
Gaia Spadarella, Alessandro Di Minno, Maria Benedetta Donati, Mauro Mormile, Itala Ventre & Giovanni Di Minno. (2020) From unfractionated heparin to pentasaccharide: Paradigm of rigorous science growing in the understanding of the in vivo thrombin generation. Blood Reviews 39, pages 100613.
Crossref
Crossref
Maya Serhal & Marcelo P. V. Gomes. 2018. Anticoagulation Therapy. Anticoagulation Therapy
133
150
.
Deborah Hornacek & Marcelo P. V. Gomes. 2018. Anticoagulation Therapy. Anticoagulation Therapy
105
131
.
Joseph Meltzer & Joseph R. Guenzer. (2017) Anticoagulant Reversal and Anesthetic Considerations. Anesthesiology Clinics 35:2, pages 191-205.
Crossref
Crossref
Ulla K.E. Hedner. 2017. Treating Life-Threatening Bleedings. Treating Life-Threatening Bleedings
27
36
.
H.C. Hemker. (2016) A century of heparin: past, present and future. Journal of Thrombosis and Haemostasis 14:12, pages 2329-2338.
Crossref
Crossref
Giangiacomo Torri & Annamaria Naggi. (2016) Heparin centenary – an ever-young life-saving drug. International Journal of Cardiology 212, pages S1-S4.
Crossref
Crossref
Fatemeh Saheb Sharif-Askari, Syed Azhar Syed Sulaiman & Narjes Saheb Sharif-Askari. 2017. Thrombosis and Embolism: from Research to Clinical Practice. Thrombosis and Embolism: from Research to Clinical Practice
101
114
.
Lukram Sidartha, Mohit Sharma, Sunil Dixit & Anil Sharma. (2014) THE ROLE OF XANTHINOL NICOTINATE WITH HEPARIN AND DEXTRAN-40 IN POST TRAUMATIC ARTERIAL REPAIR CASES WHERE IMMEDIATE DISTAL PULSATION IS ABSENT: A PROSPECTIVE STUDY IN 150 CASES PRESENTING MORE THAN 10 HOURS POST INJURY. Journal of Evolution of Medical and Dental Sciences 3:38, pages 9837-9846.
Crossref
Crossref
Nobuyuki AKITA, Koji SUZUKI & Tatsuya HAYASHI. (2014) Structure and function of antithrombin. Japanese Journal of Thrombosis and Hemostasis 25:1, pages 23-32.
Crossref
Crossref
Andrea Morelli. 2013. Production of Plasma Proteins for Therapeutic Use. Production of Plasma Proteins for Therapeutic Use
147
157
.
Marilyn Johnston. 2013. Quality in Laboratory Hemostasis and Thrombosis. Quality in Laboratory Hemostasis and Thrombosis
244
252
.
Serena Valsami & Lars M. Asmis. (2013) A Brief Review of 50 Years of Perioperative Thrombosis and Hemostasis Management. Seminars in Hematology 50:2, pages 79-87.
Crossref
Crossref
Drago R. Sliskovic. 2013. Drug Discovery. Drug Discovery
141
204
.
David A. Garcia, Trevor P. Baglin, Jeffrey I. Weitz & Meyer Michel Samama. (2012) Parenteral Anticoagulants. Chest 141:2, pages e24S-e43S.
Crossref
Crossref
T. W. Barrowcliffe. 2012. Heparin - A Century of Progress. Heparin - A Century of Progress
3
22
.
H. SAITO, T. MATSUSHITA & T. KOJIMA. (2011) Historical perspective and future direction of coagulation research. Journal of Thrombosis and Haemostasis 9, pages 352-363.
Crossref
Crossref
Douglas M. Tollefsen. 2010. Glycosaminoglycans in Development, Health and Disease. Glycosaminoglycans in Development, Health and Disease
351
372
.
Nicholas W. Shworak, Takashi Kobayashi, Ariane de Agostini & Nicole C. Smits. 2010. Glycosaminoglycans in Development, Health and Disease. Glycosaminoglycans in Development, Health and Disease
153
178
.
I. Elalamy. (2010) Héparines : structure, propriétés pharmacologiques et activités. EMC - Hématologie 5:3, pages 1-12.
Crossref
Crossref
Jack Hirsh, Kenneth A. Bauer, Maria B. Donati, Michael Gould, Meyer M. Samama & Jeffrey I. Weitz. (2008) Parenteral Anticoagulants. Chest 133:6, pages 141S-159S.
Crossref
Crossref
Walter Jeske, Debra Hoppensteadt, Asad Shaikh, Jeanine Walenga & Mamdouh Bakhos. 2007. Textbook of Interventional Cardiovascular Pharmacology. Textbook of Interventional Cardiovascular Pharmacology
1
29
.
Kazunori IWADE. (2006) Overview of the anticoagulant therapy in Japan. Japanese Journal of Thrombosis and Hemostasis 17:6, pages 664-675.
Crossref
Crossref
Jeanine M. Walenga, Walter P. Jeske & Jawed Fareed. 2005. Chemistry and Biology of Heparin and Heparan Sulfate. Chemistry and Biology of Heparin and Heparan Sulfate
143
177
.
P.M. SANDSET & U. ABILDGAARD. (2004) Tissue factor pathway inhibitor revisited. Journal of Thrombosis and Haemostasis 2:12, pages 2242-2243.
Crossref
Crossref
Jack Hirsh & Robert Raschke. (2004) Heparin and Low-Molecular-Weight Heparin. Chest 126:3, pages 188S-203S.
Crossref
Crossref
Maurice Petitou. (2003) De l’héparine aux oligosaccharides antithrombotiques de synthèse. Bulletin de l'Académie Nationale de Médecine 187:1, pages 47-57.
Crossref
Crossref
Takahiro Yamada, Hideto Yamada, Mamoru Morikawa, Emi H. Kato, Tatsuro Kishida, Yoshito Ohnaka, Hiroki Nikaido, Tetsuo Ozawa & Seiichiro Fujimoto. (2010) Management of Pregnancy with Congenital Antithrombin III Deficiency: Two Case Reports and a Review of the Literature. Journal of Obstetrics and Gynaecology Research 27:4, pages 189-197.
Crossref
Crossref
Jack Hirsh, Theodore E. Warkentin, Stephen G. Shaughnessy, Sonia S. Anand, Jonathan L. Halperin, Robert Raschke, Christopher Granger, E. Magnus Ohman & James E. Dalen. (2001) Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety. Chest 119:1, pages 64S-94S.
Crossref
Crossref
Steve Kitchen. (2008) Problems In Laboratory Monitoring Of Heparin Dosage. British Journal of Haematology 111:2, pages 397-406.
Crossref
Crossref
Steve Kitchen. (2000) Problems In Laboratory Monitoring Of Heparin Dosage. British Journal of Haematology 111:2, pages 397-406.
Crossref
Crossref
Toshikazu Kubo, Hajime Tsuji, Takuaki Yamamoto, Hirofumi Nakahara, Masao Nakagawa & Yasusuke Hirasawa. (2000) Antithrombin III Deficiency in a Patient With Multifocal Osteonecrosis. Clinical Orthopaedics and Related Research 378, pages 306-311.
Crossref
Crossref
D. A. Lane. 1999. Hämostaseologie. Hämostaseologie
310
314
.
Jamil Bitar, Salim Dabaghi, Selim Sekili & Neil S. Kleiman. 1998. Unstable Coronary Artery Syndromes Pathophysiology, Diagnosis and Treatment. Unstable Coronary Artery Syndromes Pathophysiology, Diagnosis and Treatment
241
275
.
Nabila Seddiki, Elisabeth Mbemba, Didier Letourneur, Loyda Ylisastigui, Abdelaziz Benjouad, Line Saffar, Jean Claude Gluckman, Jacqueline Jozefonvicz & Liliane Gattegno. (1997) Antiviral activity of derivatized dextrans on HIV-1 infection of primary macrophages and blood lymphocytes. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1362:1, pages 47-55.
Crossref
Crossref
Jeanine M. Walenga, Walter P. Jeske, Lucienne Bara, Meyer M. Samama & Jawed Fareed. (1997) BIOCHEMICAL AND PHARMACOLOGIC RATIONALE FOR THE DEVELOPMENT OF A SYNTHETIC HEPARIN PENTASACCHARIDE. Thrombosis Research 86:1, pages 1-36.
Crossref
Crossref
DANIEL J CASTELINO & HATEM H SALEM. (2008) Natural anticoagulants and the liver. Journal of Gastroenterology and Hepatology 12:1, pages 77-83.
Crossref
Crossref
Eric Camerer, Anne-Brit Kolstø & Hans Prydz. (1996) Cell biology of tissue factor, the principal initiator of blood coagulation. Thrombosis Research 81:1, pages 1-41.
Crossref
Crossref
Walter Jeske, Jawed Fareed, Debra Hoppensteadt & Benito Casu. 1996. Nonanticoagulant Actions of Glycosaminoglycans. Nonanticoagulant Actions of Glycosaminoglycans
65
87
.
Markku T. Salmenperä, Jerrold H. Levy & Laurence A. Harker. 1995. Cardiopulmonary Bypass. Cardiopulmonary Bypass
88
113
.
B Mille, J Watton, T W Barrowcliffe, J C Mani & D A Lane. (1994) Role of N- and C-terminal amino acids in antithrombin binding to pentasaccharide.. Journal of Biological Chemistry 269:47, pages 29435-29443.
Crossref
Crossref
LUCIA LOPALCO, FRANCA CICCOMASCOLO, PAOLA LANZA, GIORGIO ZOPPETTI, IDA CARAMAZZA, FLAVIO LEONI, ALBERTO BERETTA & ANTONIO G. SICCARDI. (1994) Anti-HIV Type 1 Properties of Chemically Modified Heparins with Diminished Anticoagulant Activity. AIDS Research and Human Retroviruses 10:7, pages 787-793.
Crossref
Crossref
J HirshV Fuster. (1994) Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association.. Circulation 89:3, pages 1449-1468.
Crossref
Crossref
D.J. Perry. (1994) Antithrombin and its inherited deficiencies. Blood Reviews 8:1, pages 37-55.
Crossref
Crossref
R L MuellerS Scheidt. (1994) History of drugs for thrombotic disease. Discovery, development, and directions for the future.. Circulation 89:1, pages 432-449.
Crossref
Crossref
Bonnie Rush Moore & Kenneth W. Hinchcliff. (2008) Heparin: A Review of its Pharmacology and Therapeutic Use in Horses. Journal of Veterinary Internal Medicine 8:1, pages 26-35.
Crossref
Crossref
R.T. Barrow, J.F. Healey & P. Lollar. (1994) Inhibition by heparin of thrombin-catalyzed activation of the factor VIII-von Willebrand factor complex.. Journal of Biological Chemistry 269:1, pages 593-598.
Crossref
Crossref
M. Sarret. 1994. Anticoagulation. Anticoagulation
55
118
.
Charles S. Eby. (1993) A Review of the Hypercoagulable State. Hematology/Oncology Clinics of North America 7:6, pages 1121-1142.
Crossref
Crossref
Anne Karin Lindahl, Ulrich Abildgaard & Rita Staalesen. (1991) The anticoagulant effect in heparinized blood and plasma resulting from interactions with extrinsic pathway inhibitor. Thrombosis Research 64:2, pages 155-168.
Crossref
Crossref
John A. Oates, Alastair J.J. Wood & Jack Hirsh. (1991) Heparin. New England Journal of Medicine 324:22, pages 1565-1574.
Crossref
Crossref
R. SALTE, K. NORBERG & O. R. ØDEGAARD. (2006)
Do extracellular products of
Aeromonas salmonicida
induce thrombosis by entering the fish coagulation system at factor X?
. Journal of Fish Diseases 14:3, pages 401-406.
Crossref
Crossref
H. C. Hemker, S. Béguin & T. Lindhout. 1991. Coagulation and Blood Transfusion. Coagulation and Blood Transfusion
3
16
.
Eiji Nakanishi, Hiroko Sato & Akio Nakajima. (1990) Sedimentation study on the binding of fibrinogen or of antithrombin III with acidic polysaccharides including heparin. Polymer Bulletin 24:4, pages 429-435.
Crossref
Crossref
R. Menta, L. Mottola & E. Invernizzi. (2018) AT III - Ruolo e Significato in Nefrologia e Nell'unità di Terapia Intensiva. Giornale di Tecniche Nefrologiche e Dialitiche 2:3, pages 5-16.
Crossref
Crossref
Craig M. Jackson. (1990) 1 Mechanism of heparin action. Baillière's Clinical Haematology 3:3, pages 483-504.
Crossref
Crossref
D. A. Lane, R. Caso, R. J. Olds & S. L. Thein. 1990. New Trends in Haemostasis. New Trends in Haemostasis
188
201
.
W. Schramm, M. Spannagl & H. P. Schwarz. 1990. 20. Hämophilie-Symposion Hamburg 1989. 20. Hämophilie-Symposion Hamburg 1989
263
274
.
David A. Lane & Rosanna Caso. (1989) 9 Antithrombin: Structure, genomic organization, function and inherited deficiency. Baillière's Clinical Haematology 2:4, pages 961-998.
Crossref
Crossref
Robert D. Rosenberg. (1989) Introduction. The American Journal of Medicine 87:3, pages S1.
Crossref
Crossref
CHARLOTTE W. PRATT, HERBERT C. WHINNA, JAMES B. MEADE, RITA E. TREANOR & FRANK C. CHURCH. (1989) Physicochemical Aspects of Heparin Cofactor II. Annals of the New York Academy of Sciences 556:1 Heparin and R, pages 104-115.
Crossref
Crossref
J Y Chang. (1989) Binding of Heparin to Human Antithrombin III Activates Selective Chemical Modification at Lysine 236. Journal of Biological Chemistry 264:6, pages 3111-3115.
Crossref
Crossref
W E Van Nostrand, L D McKay, J B Baker & D D Cunningham. (1988) Functional and structural similarities between protease nexin I and C1 inhibitor.. Journal of Biological Chemistry 263:8, pages 3979-3983.
Crossref
Crossref
T H Carlson, T Babcock, A C Atencio, C Levinson & H R Mora. (1988) Behavior of antithrombin III isoforms on immobilized heparins. Evidence that the isoforms bind to different numbers of low-affinity heparin sites.. Journal of Biological Chemistry 263:5, pages 2187-2194.
Crossref
Crossref
R. Zimmermann. 1988. Hämostase in Anästhesie und Intensivmedizin. Hämostase in Anästhesie und Intensivmedizin
58
67
.
James A. Marcum & Robert D. Rosenberg. 1988. Endothelial Cell Biology in Health and Disease. Endothelial Cell Biology in Health and Disease
207
228
.
C S Liu & J Y Chang. (1987) The heparin binding site of human antithrombin III. Selective chemical modification at Lys114, Lys125, and Lys287 impairs its heparin cofactor activity.. Journal of Biological Chemistry 262:36, pages 17356-17361.
Crossref
Crossref
Chen‐Sheng LIU & Jui‐Yoa CHANG. (2005) Probing the heparin‐binding domain of human antithrombin III with V8 protease. European Journal of Biochemistry 167:2, pages 247-252.
Crossref
Crossref
C B Peterson, C M Noyes, J M Pecon, F C Church & M N Blackburn. (1987) Identification of a lysyl residue in antithrombin which is essential for heparin binding.. Journal of Biological Chemistry 262:17, pages 8061-8065.
Crossref
Crossref
James A. Marcum, Christopher F. Reilly & Robert D. Rosenberg. 1987. Biology of Proteoglycans. Biology of Proteoglycans
301
343
.
J. Caix, A. Perrot Minnot, A. Beziade, L. Vuillemin, F. Belloc, Ch. Baquey & D. Ducassou. (1987) Conditions for radioiodination of antithrombin III retaining its biological properties. International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes 38:12, pages 1003-1006.
Crossref
Crossref
G Hortin, D M Tollefsen & A W Strauss. (1986) Identification of two sites of sulfation of human heparin cofactor II.. Journal of Biological Chemistry 261:34, pages 15827-15830.
Crossref
Crossref
Genichiro Oshima. (1986) Inactivation of bovine chymotrypsin by bovine antithrombin iii. Thrombosis Research 44:3, pages 315-325.
Crossref
Crossref
X.J. Yu, A.M. Fischer, D. Muller, A. Bros, J. Tapon-Bretaudiere & J. Jozefonvicz. (1986) Affinity chromatography of thrombin on modified polystyrene resins. Journal of Chromatography B: Biomedical Sciences and Applications 376, pages 429-435.
Crossref
Crossref
Michael J. Griffith. 1986. Blood Coagulation. Blood Coagulation
259
283
.
J Y Chang & T H Tran. (1986) Antithrombin III Basel. Identification of a Pro-Leu substitution in a hereditary abnormal antithrombin with impaired heparin cofactor activity.. Journal of Biological Chemistry 261:3, pages 1174-1176.
Crossref
Crossref
Hans-Peter T. Ekre, Bo Fjellner & Östen Hägermark. (1986) Inhibition of complement dependent experimental inflammation in human skin by different heparin fractions. International Journal of Immunopharmacology 8:3, pages 277-286.
Crossref
Crossref
D. Muller, X.J. Yu, A.M. Fischer, A. Bros & J. Jozefonvicz. (1986) High performance affinity chromatography of human thrombin on modified polystyrene resins. Journal of Chromatography A 359, pages 351-357.
Crossref
Crossref
Robert W. Colman & Andrei Z. Budzynski. 2011. Comprehensive Physiology. Comprehensive Physiology
495
544
.
Michael J. Griffith, Claudia M. Noyes, Jo Ann Tyndall & Frank C. Church. (2002) Structural evidence for leucine at the reactive site of heparin cofactor II. Biochemistry 24:24, pages 6777-6782.
Crossref
Crossref
Eric A. Jaffe, Douglas Armellino & Douglas M. Tollefsen. (1985) Biosynthesis of functionally active heparin cofactor II by a human hepatoma-derived cell line. Biochemical and Biophysical Research Communications 132:1, pages 368-374.
Crossref
Crossref
TriH. Tran, GermanA. Marbet & François Duckert. (1985) ASSOCIATION OF HEREDITARY HEPARIN CO-FACTOR II DEFICIENCY WITH THROMBOSIS. The Lancet 326:8452, pages 413-414.
Crossref
Crossref
M J Griffith, C M Noyes & F C Church. (1985) Reactive site peptide structural similarity between heparin cofactor II and antithrombin III.. Journal of Biological Chemistry 260:4, pages 2218-2225.
Crossref
Crossref
Sam Schulman. (2009) STUDIES ON THE MEDICAL TREATMENT OF DEEP VEIN THROMBOSIS. Acta Medica Scandinavica 218:S704, pages 3-68.
Crossref
Crossref
Benito Casu. 1985. Advances in Carbohydrate Chemistry and Biochemistry Volume 43. Advances in Carbohydrate Chemistry and Biochemistry Volume 43
51
134
.
Audrey Larack Stone. (1985) Far-ultraviolet circular dichroism and uronic acid components of anticoagulant deca-, dodeca-, tetradeca-, and octadecasaccharide heparin fractions. Archives of Biochemistry and Biophysics 236:1, pages 342-353.
Crossref
Crossref
B. A. Kudryashov, V. E. Pastorova & L. A. Lyapina. (1985) Plasma anticoagulant and nonenzymic fibrinolytic activity after intravenous injection of heparin-antithrombin III complex into animals. Bulletin of Experimental Biology and Medicine 99:1, pages 76-78.
Crossref
Crossref
Jeffrey Denton & David A. Lane. 1985. Advances in Hemostasis and Thrombosis. Advances in Hemostasis and Thrombosis
251
260
.
Frank C. Church & Michael J. Griffith. (1984) Evidence for essential lysines in heparin cofactor II. Biochemical and Biophysical Research Communications 124:3, pages 745-751.
Crossref
Crossref
Ewa Marciniak. (1984) Physiology of antithrombin III. La Ricerca in Clinica e in Laboratorio 14:3, pages 475-483.
Crossref
Crossref
Jui-Yoa Chang. (1984) A cross-linking mechanism for the heparin-enhanced antithrombin-thrombin reaction?. FEBS Letters 171:2, pages 157-159.
Crossref
Crossref
C. Boisson, D. Gulino, J. Jozefonvicz, A.M. Fischer & J Tapon-Bretaudiere. (1984) Antithrombic properties of insoluble modified polystyrene : Part I. Thrombosis Research 34:4, pages 269-276.
Crossref
Crossref
P. Lambin, F. Pochon & M. Steinbuch. 1984. Proteases. Proteases
263
272
.
M E Nesheim. (1983) A simple rate law that describes the kinetics of the heparin-catalyzed reaction between antithrombin III and thrombin.. Journal of Biological Chemistry 258:23, pages 14708-14717.
Crossref
Crossref
D M Tollefsen, C A Pestka & W J Monafo. (1983) Activation of heparin cofactor II by dermatan sulfate.. Journal of Biological Chemistry 258:11, pages 6713-6716.
Crossref
Crossref
Michael J. Griffith & German A. Marbet. (1983) Dermatan sulfate and heparin can be fractionated by affinity for heparin cofactor II. Biochemical and Biophysical Research Communications 112:2, pages 663-670.
Crossref
Crossref
Susan Elödi & Pál Elödi. (1983) Surface-governed molecular regulation of blood coagulation. Molecular Aspects of Medicine 6:4, pages 291-353.
Crossref
Crossref
Derek OgstonDerek Ogston. 1983. The Physiology of Hemostasis. The Physiology of Hemostasis
57
140
.
M J Griffith. (1982) Kinetics of the heparin-enhanced antithrombin III/thrombin reaction. Evidence for a template model for the mechanism of action of heparin.. Journal of Biological Chemistry 257:13, pages 7360-7365.
Crossref
Crossref
Michael J. Griffith. (1982) Measurement of the heparin enhanced-antithrombin III/thrombin reaction rate in the presence of synthetic substrate. Thrombosis Research 25:3, pages 245-253.
Crossref
Crossref
P. Wunderwald, W.J. Schrenk & H. Port. (1982) Antithrombin bm from human plasma: An antithrombin binding moderately to heparin. Thrombosis Research 25:3, pages 177-191.
Crossref
Crossref
I. Bj�rk & U. Lindahl. (1982) Mechanism of the anticoagulant action of heparin. Molecular and Cellular Biochemistry 48:3, pages 161-182.
Crossref
Crossref
Ann K. Morton, Haydn E. Edwards, John C. Allen & Glyn O. Phillips. (1981) An evaluation of the oral administration of commercial and fractionated heparin samples in rats. International Journal of Pharmaceutics 9:4, pages 321-335.
Crossref
Crossref
M. Ryde, H. Eriksson & O. Tangen. (1981) Studies on the different mechanisms by which heparin and polysulphated xylan (PZ 68) inhibit blood coagulation in man. Thrombosis Research 23:4-5, pages 435-445.
Crossref
Crossref
Ramzy S. Labib, Magda H. Azab & Nagi W. Farag. (1981) Effects of Cerastes cerastes (Egyptian sand viper) and Cerastes vipera (Sahara sand viper) snake venoms on blood coagulation: Separation of coagulant and anticoagulant factors and their correlation with arginine esterase and protease activities. Toxicon 19:1, pages 85-94.
Crossref
Crossref
V. V. Kakkar. 1981. Thrombose und Embolie. Thrombose und Embolie
180
193
.
E.B. Reeve, B. Leonard, S.H. Wentland & P. Damus. (1980) Studies with 131I-labelled antithrombin III in dogs. Thrombosis Research 20:4, pages 375-389.
Crossref
Crossref
B. Radhakrishnamurthy, F. Smart, E.R. DalferesJrJr & G.S. Berenson. (1980) Isolation and characterization of proteoglycans from bovine lung.. Journal of Biological Chemistry 255:16, pages 7575-7582.
Crossref
Crossref
Roland Einarsson, Ewa Jahr, Eva Stiber, Lena Engman, Henrik Lundström & Lars-Olov Andersson. (1980) Effects of the reduction and S-carbamidomethylation on the conformation, activity and heparin-binding capacity of human antithrombin III. Biochimica et Biophysica Acta (BBA) - Protein Structure 624:2, pages 386-396.
Crossref
Crossref
M. VERSTRAETE. (2009) POTENTIAL AND PROBLEMS WITH THE CLINICAL USE OF HEPARIN. Scandinavian Journal of Haematology 24:S36, pages 1-24.
Crossref
Crossref
M.O. Longas, W.S. Ferguson & T.H. Finlay. (1980) A disulfide bond in antithrombin is required for heparin-accelerated thrombin inactivation.. Journal of Biological Chemistry 255:8, pages 3436-3441.
Crossref
Crossref
Michael J Griffith, Gary Beavers, Henry S Kingdon & Roger L Lundblad. (1980) Effect of monovalent cations on the heparin-enhanced antithrombin III/thrombin reaction. Thrombosis Research 17:1-2, pages 29-39.
Crossref
Crossref
Michael J. Griffith, Henry S. Kingdom & Roger L. Lundblad. (1979) The interaction of heparin with human α-thrombin: Effect on the hydrolysis of anilide tripeptide substrates. Archives of Biochemistry and Biophysics 195:2, pages 378-384.
Crossref
Crossref
Michael J. Griffith, Henry S. Kingdon & Roger L. Lundblad. (1979) Inhibition of the heparin-antithrombin III/thrombin reaction by active site blocked-thrombin. Biochemical and Biophysical Research Communications 87:3, pages 686-692.
Crossref
Crossref
Wayne W. Fish, Kerstin Orre & Ingemar Björk. (1979) The production of an inactive form of antithrombin through limited proteolysis by thrombin. FEBS Letters 98:1, pages 103-106.
Crossref
Crossref
H. Z. Movat. 1979. Bradykinin, Kallidin and Kallikrein. Bradykinin, Kallidin and Kallikrein
1
89
.
Stanford Wessler & Sanford N. Gitel. (1978) Coagulation for cardiologists. American Heart Journal 96:6, pages 811-823.
Crossref
Crossref
Adriaan Bantjes. (2007) Clotting Phenomena at the Blood‐Polymer Interface and Development of Blood Compatible Polymeric Surfaces. British Polymer Journal 10:4, pages 267-274.
Crossref
Crossref
Mark W. Pomerantz & Whyte G. Owen. (1978) A catalytic role for heparin. Biochimica et Biophysica Acta (BBA) - Protein Structure 535:1, pages 66-77.
Crossref
Crossref
Birgitta Nordenman & Ingemar Björk. (1978) Studies on the binding of heparin to prothrombin and thrombin and the effect of heparin-binding on thrombin activity. Thrombosis Research 12:5, pages 755-765.
Crossref
Crossref
Roland Einarsson. (1978) The increase in human antithrombin III tryptophan fluorescence produced by heparin. Biochimica et Biophysica Acta (BBA) - Protein Structure 534:1, pages 165-168.
Crossref
Crossref
HansG Schipper, LaurensH Kahlé, CharlesS.P Jenkins & JAN.W.TEN Cate. (1978) ANTITHROMBIN-III TRANSFUSION IN DISSEMINATED INTRAVASCULAR COAGULATION. The Lancet 311:8069, pages 854-856.
Crossref
Crossref
Lilian Johansson, Ulla Hedner & Inga Marie Nilsson. (2009) Familial Antithrombin III Deficiency as Pathogenesis of Deep Venous Thrombosis. Acta Medica Scandinavica 204:1-6, pages 491-495.
Crossref
Crossref
I. Danishefsky, A. Zweben & B.L. Slomiany. (1978) Human antithrombin III. Carbohydrate components and associated glycolipid.. Journal of Biological Chemistry 253:1, pages 32-37.
Crossref
Crossref
Jolyon Jesty. (1978) The inhibition of activated bovine coagulation factors X and VII by antithrombin III. Archives of Biochemistry and Biophysics 185:1, pages 165-173.
Crossref
Crossref
Henry Z. Movat. 1979. Reviews of Physiology, Biochemistry and Pharmacology, Volume 86. Reviews of Physiology, Biochemistry and Pharmacology, Volume 86
143
202
.
V. V. Kakkar. (1978) The current status of low-dose heparin in the prophylaxis of thrombophlebitis and pulmonary embolism. World Journal of Surgery 2:1, pages 3-13.
Crossref
Crossref
Roland Einarsson. (2009) QUENCHING OF TRYPTOPHAN FLUORESCENCE IN HUMAN ANTITHROMBIN III BY IODIDE ION. International Journal of Peptide and Protein Research 10:5, pages 342-348.
Crossref
Crossref
M.J.P. Kahn, W. Schandevijl, G. Philipi & H.L.L. Frank. (1977) The contribution of α1-antitrypsin to the total antitrypsin activity of human serum. a study of two phenotype pi oo individuals. Clinica Chimica Acta 80:3, pages 513-518.
Crossref
Crossref
I. Danishefsky, M. Ahrens & S. Klein. (1977) Effect of heparin modification on its activity in enhancing the inhibition of thrombin by antithrombin III. Biochimica et Biophysica Acta (BBA) - General Subjects 498:1, pages 215-222.
Crossref
Crossref
Péter Arányi, József Batke & Raymund Machovich. (1977) Remarks on the interaction of thrombin and heparin. Archives of Biochemistry and Biophysics 181:2, pages 678-679.
Crossref
Crossref
L-O. Andersson, L. Engman & E. Henningsson. (1977) Crossed immunoelectrophoresis as applied to studies on complex formation. The binding of heparin to antithrombin III and the antithrombin III-thrombin complex. Journal of Immunological Methods 14:3-4, pages 271-281.
Crossref
Crossref
Earl W. Davie & Donald J. Hanahan. 1977. The Plasma Proteins. The Plasma Proteins
421
544
.
R. Losito, G. Barlow & E. Lemieux. (1977) 3H-heparin and antithrombin III in the isolated liver perfusion. Thrombosis Research 10:1, pages 83-93.
Crossref
Crossref
Clement E. Burrowes & Henry Z. Movat. (1977) Isolation of antithrombin III from human plasma: Its separation from α1-antitrypsin. Biochemical and Biophysical Research Communications 74:1, pages 140-149.
Crossref
Crossref
German B. Villanueva & Isidore Danishefsky. (1977) Evidence for a heparin-induced conformational change on antithrombin III. Biochemical and Biophysical Research Communications 74:2, pages 803-809.
Crossref
Crossref
Roland Einarsson & Lars-Olov Andersson. (1977) Binding of heparin to human antithrombin III as studied by measurements of tryptophan fluorescence. Biochimica et Biophysica Acta (BBA) - Protein Structure 490:1, pages 104-111.
Crossref
Crossref
Bo Furugren, Lars-Olov Andersson & Roland Einarsson. (1977) Small-angle X-ray scattering studies on human antithrombin III and its complex with heparin. Archives of Biochemistry and Biophysics 178:2, pages 419-424.
Crossref
Crossref
M. Baum, H. J. Harder, H. F. Cascorbi, Ch. Lehmann, H. Lutz, G. Thews, J. Grote, O. Harth, M. Halmágyi, H. Foitzik, P. Lawin, K. Irsigler, A. Doenicke & B. Grote. 1977. Lehrbuch der Anaesthesiologie Reanimation und Intensivtherapie. Lehrbuch der Anaesthesiologie Reanimation und Intensivtherapie
3
237
.
Jocelyn Spragg & K. Frank Austen. 1977. Immunopharmacology. Immunopharmacology
125
143
.
N Stead, A P Kaplan & R D Rosenberg. (1976) Inhibition of activated factor XII by antithrombin-heparin cofactor.. Journal of Biological Chemistry 251:21, pages 6481-6488.
Crossref
Crossref
Ingemar BJÖRK & Birgitta NORDENMAN. (2008) Acceleration of the Reaction between, Thrombin and Antithrombin III by Non‐stoichiometric Amounts of Heparin. European Journal of Biochemistry 68:2, pages 507-511.
Crossref
Crossref
Eddy H.H. Li, John W. FentonIIII & Richard D. Feinman. (1976) The role of heparin in the thrombin-antithrombin III reaction. Archives of Biochemistry and Biophysics 175:1, pages 153-159.
Crossref
Crossref
O.R. Ødegård & A.N. Teien. (1976) Antithrombin III, heparin cofactor and antifactor Xa in a clinical material. Thrombosis Research 8:2, pages 173-178.
Crossref
Crossref
Kotoku Kurachi, Kazuo Fujikawa, Gottfried Schmer & Earl W. Davie. (2002) Inhibition of bovine factor IXa and factor Xa.beta. by antithrombin III. Biochemistry 15:2, pages 373-377.
Crossref
Crossref
Kotoku Kurachi, Gottfried Schmer, Mark A. Hermodson, David C. Teller & Earl W. Davie. (2002) Characterization of human, bovine, and horse antithrombin III. Biochemistry 15:2, pages 368-373.
Crossref
Crossref
Paul S. Damus & Robert D. Rosenberg. 1976. Part B: Proteolytic Enzymes. Part B: Proteolytic Enzymes
653
669
.
E. Thaler & G. Schmer. (2008) A Simple Two‐step Isolation Procedure for Human and Bovine Antithrombin II/III (Heparin Cofactor): a Comparison of Two Methods. British Journal of Haematology 31:2, pages 233-243.
Crossref
Crossref
Anthony A. Magnin & William B. Lawson. (1975) Simultaneous determination of plasma prothrombin and antithrombin III (heparin cofactor). Thrombosis Research 7:4, pages 555-566.
Crossref
Crossref
Raymund Machovich, György Blaskó, Ágnes Himer & Károly Szikla. (1975) Effect of sodium and potassium ions on the activity of human antithrombin-heparin cofactor. Thrombosis Research 7:2, pages 305-313.
Crossref
Crossref
Clement E Burrowes, Flavio M Habal & Henry Z Movat. (1975) The inhibition of human plasma Kallikrein by antithrombin III. Thrombosis Research 7:1, pages 175-183.
Crossref
Crossref
Sanford N Gitel & Stanford Wessler. (1975) Plasma antithrombin III: A quantitative assay of biological activity. Thrombosis Research 7:1, pages 5-16.
Crossref
Crossref
O.R Ødegård, M Lie & U Abildgaard. (1975) Heparin cofactor activity measured with an amidolytic method. Thrombosis Research 6:4, pages 287-294.
Crossref
Crossref
Howard L. Bleich, Emily S. Boro & Robert D. Rosenberg. (1975) Actions and Interactions of Antithrombin and Heparin. New England Journal of Medicine 292:3, pages 146-151.
Crossref
Crossref
Raymund Machovich, György Blaskó & LászlóA. Pálos. (1975) Action of heparin on thrombin-antithrombin reaction. Biochimica et Biophysica Acta (BBA) - Protein Structure 379:1, pages 193-200.
Crossref
Crossref
Stanford Wessler. 1975. Thromboembolism. Thromboembolism
9
28
.
Anna D. Borsodi, Ralph A. Bradshaw, Indulal K. Rughani & Robert M. Bruce. 1975. Heparin. Heparin
249
253
.
Robert D. Rosenberg. 1975. Heparin. Heparin
217
238
.
Milica Brozovic & D. R. Bangham. 1975. Heparin. Heparin
163
179
.
Maggie Miller-Andersson, Håkan Borg & Lars-Olov Andersson. (1974) Purification of antithrombin III by affinity chromatography. Thrombosis Research 5:4, pages 439-452.
Crossref
Crossref
G. Tatra, W. Gruber & G. Breitenecker. (1974) Quantitative immunologische Bestimmung der Antithrombin III-Konzentration bei normaler Schwangerschaft und post partumQuantitative immunological determination of Antithrombin III concentration during normal pregnancy and post partum. Archiv für Gynäkologie 217:2, pages 127-130.
Crossref
Crossref
U. Abildgaard, O.R. Ødegård, P. Kierulf & D.S. Pepper. (1974) Influence of platelet factor 4 on inhibited thrombin substrate reactions. Thrombosis Research 5:2, pages 185-196.
Crossref
Crossref
D. E. G. Austen & C. R. Rizza. 1974. Structure and Function of Plasma Proteins. Structure and Function of Plasma Proteins
169
193
.
H. EKERT & R. SESHADRI. (1973) HEPRIN TREATMENT IN CHILDHOOD AND ITS EFFECT ON MONITORING TESTS. Journal of Paediatrics and Child Health 9:4, pages 269-275.
Crossref
Crossref
Ulla Hedner & Inga Marie Nilsson. (1973) Antithrombin III in a clinical material. Thrombosis Research 3:6, pages 631-641.
Crossref
Crossref
Robert D. Rosenberg & Paul S. Damus. (1973) The Purification and Mechanism of Action of Human Antithrombin-Heparin Cofactor. Journal of Biological Chemistry 248:18, pages 6490-6505.
Crossref
Crossref
Harald Arnesen. (2009) Studies on the Thrombin Clotting Time. Scandinavian Journal of Haematology 10:4, pages 291-297.
Crossref
Crossref
Nils Egberg. (2009) COAGULATION STUDIES IN PATIENTS TREATED WITH DEFIBRASE. Acta Medica Scandinavica 194:1-6, pages 291-302.
Crossref
Crossref
NATHANIEL F. RODMAN. 1973. The Inflammatory Process. The Inflammatory Process
363
392
.
Peter G. Barton & E. Thye Yin. 1973. Metabolic Inhibitors. Metabolic Inhibitors
215
310
.
P. A. Owren & H. Stormorken. 1973. Ergebnisse der Physiologie Reviews of Physiology, Volume 68. Ergebnisse der Physiologie Reviews of Physiology, Volume 68
1
53
.
Campbell W. McMillan, Andrew E. Weiss & A. Myron Johnson. (1972) Acquired Coagulation Disorders in Children. Pediatric Clinics of North America 19:4, pages 1029-1045.
Crossref
Crossref
M. Wickerhauser & J. T. Sgouris. (1972) Development of Large-Scale Fractionation Methods. Vox Sanguinis 22:2, pages 137-160.
Crossref
Crossref
Piergiorgio Righetti & Camillo Secchi. (1972) Preparative polyacrylamide gel electrophoresis. Journal of Chromatography A 72:1, pages 165-175.
Crossref
Crossref
C. Eika. (2009) Inhibition of Thrombin‐Induced Aggregation of Human Platelets by Heparin and Antithrombin III. Scandinavian Journal of Haematology 8:4, pages 250-256.
Crossref
Crossref
C. Eika. (2009) Inhibition of Thrombin Induced Aggregation of Human Platelets by Heparin. Scandinavian Journal of Haematology 8:3, pages 216-222.
Crossref
Crossref
E.T. Yin, S. Wessler & Pamela J. Stoll. (1971) Identity of Plasma-activated Factor X Inhibitor with Antithrombin III and Heparin Cofactor. Journal of Biological Chemistry 246:11, pages 3712-3719.
Crossref
Crossref
Harald Arnesen. (2009) 31. FIBRINOGEN DEGRADATION PRODUCTS AND FIBRINOGEN TO FIBRIN CONVERSION. Scandinavian Journal of Haematology 8:S13, pages 245-252.
Crossref
Crossref
M. Steinbuch. (1971) Les antiprotéases du plasma. Revue Française de Transfusion 14:1, pages 61-82.
Crossref
Crossref
C. Eika & U. Abildgaard. (2009) Inhibition of Thrombin Induced Aggregation of Human Platelets by Antithrombin III. Scandinavian Journal of Haematology 7:6, pages 460-464.
Crossref
Crossref
Rosemary Biggs, K. W. E. Denson, N. Akman, R. Borrett & M. Hadden. (2008) Antithrombin III, Antifactor Xa and Heparin. British Journal of Haematology 19:3, pages 283-305.
Crossref
Crossref
W. R. Pitney & E. Regoeczi. (2008) Inactivation of ‘Arvin’ by Plasma Proteins. British Journal of Haematology 19:1, pages 67-81.
Crossref
Crossref
M. K. Fagerhol & U. Abildgaard. (2009) Immunological Studies on Human Antithrombin III. Scandinavian Journal of Haematology 7:1, pages 10-17.
Crossref
Crossref
Frank C. Monkhouse. 1970. Proteolytic Enzymes. Proteolytic Enzymes
915
924
.
Nils Ek. (1969) Studies on Electrophoresis on Cellulose Acetate Membrane of Bovine Serum Proteins in Healthy Animals. Acta Veterinaria Scandinavica 10:2, pages 118-126.
Crossref
Crossref
U. Abildgaard. (2009) Inhibition of the Thrombin‐Fibrinogen Reaction by Heparin and Purified Cofactor. Scandinavian Journal of Haematology 5:6, pages 440-453.
Crossref
Crossref